52.8 F
San Diego
Thursday, Feb 9, 2023
-Advertisement-

Dexcom Launches Venture Arm

Dexcom, the leader in wearable continuous glucose monitors, has launched Dexcom Ventures, its first corporate venture capital fund.

The venture fund aims to invest in companies working on glucose sensing technologies and in adjacent fields of metabolic monitoring.

“We strive to be value-add strategic investors by leveraging access to Dexcom’s unique industry expertise and technology leadership,” said incoming Dexcom Ventures chief Steve Pacelli, who also serves as the company’s executive VP of strategy and corporate development.

“While we have matured as a company over the years, we still consider ourselves to be a ‘start-up’ of sorts. We feel well positioned to invest early and support our portfolio companies as they pioneer markets,” he said.

- Advertisement -

The Sorrento Valley-based company shared little details about the fund at this time, however it will be solely a Dexcom undertaking, with no additional limited partners.

Pacelli said the company will be open to evaluating investments in both early and later stage startups. The company’s initial investment in the fund was not disclosed.

Investing in Early and Late Stage

“With this entrance into the venture capital space, we believe we will be able to accelerate development for innovative companies to share our commitment to empowering greater health outcomes for customers and their clinicians,” said Kevin Sayer, chief executive at Dexcom.

“By establishing Dexcom Ventures, we believe we can advance innovative technologies that enable better health outcomes and complement our growth opportunity. I have full confidence in Steve and his team as they lead this exciting new effort.”

-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-
-Advertisement-